Malaria Vaccine Technology Roadmap
The updated Malaria Vaccine Technology Roadmap represents the result of a review process facilitated by WHO, which worked with the Malaria Vaccine Funders Group to update the 2006 roadmap’s vision and strategic goals. The roadmap forms a strategic framework that underpins the activities of the global malaria vaccine research and development community. The updated document maintains the original goal of having a licensed vaccine against Plasmodium falciparum malaria by 2015, and sets a new goal of having a second generation of malaria vaccines licensed by 2030.
Through the viral world: From quarks to multiverse
Professor Dominic Man-Kit Lam, Director of the Institute of Creativity of the Hong Kong Baptist University, a world-renowned scientist and a most distinguished Chinese artist, displayed his arts in celebration of the First WHO meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting responses. The meeting was co-organized with Professor Lam and was held at the Lam Woo International Conference Centre at the Hong Kong Baptist University from 24 to 26 January 2013.
13th Dengue International Course open for registration
WHO/PAHO Collaborating Center for the Study of Dengue and its Vector, is organizing the 13th Dengue International Course from 12 to 23 August 2013 in La Habana, Cuba.
This two-week course includes lectures, seminars and practical sessions on laboratory diagnosis, clinical care, epidemiology, vector control and community participation activities. In addition, there will be symposia dedicated to dengue diagnosis, dengue clinical management, vaccine development and dengue surveillance among others.
The meningococcal A conjugate vaccine known as MenAfriVac® can now be kept in a controlled temperature chain at temperatures of up to 40°C for up to four days. With this new regulatory approval, this innovative vaccine, which costs less than US$0.50 per dose, could help increase vaccination campaign efficiency and coverage.